Currently, Medicare coverage for anti-obesity medications is limited to indications for diabetes and cardiovascular disease. Policymakers, however, have proposed expanding…
On October 10, 2024, the National AI Advisory Committee released its draft transition plan for the incoming administration. The…
A recent survey by the National Community Pharmacists Association (NCPA) indicates that over 90 percent of independent pharmacies may choose…
A recent survey of 227 patients examining patients’ experiences with alternative funding programs (AFP) found that most patients subject to…
Join Aimed Alliance and HR.com for an upcoming webinar on December 4, 2024 at 3PM ET. Menopause and perimenopause are…
On October 18, 2024, Aimed Alliance sent a letter to the Maryland Legislative Policy Committee, urging it to make major…
On October 16, 2024, Aimed Alliance submitted a comment to Colorado’s PDAB regarding proposed changes to its Drug Affordability Review…
November 14, 2024 at 11am ET Copay Compliance: Understanding Cost-Sharing and Fiduciary Obligations for Employers Join the Alliance for Patient…
Aimed Alliance is pleased to share three new resources on prescription drug affordability boards (PDABs). PDABs are established at the…
In August 2022, President Biden signed the Inflation Reduction Act (IRA) into law. The IRA strives to enhance Medicare by…